Cargando…
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic
Autores principales: | Stavert, Robert, Meydani-Korb, Ahou, de Leon, Dianne, Osgood, Rebecca, Blau, Jessamyn, Luu, Thien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434300/ https://www.ncbi.nlm.nih.gov/pubmed/32822790 http://dx.doi.org/10.1016/j.jaad.2020.08.049 |
Ejemplares similares
-
Elasomeran: Chilblains-like lesions: case report
Publicado: (2022) -
Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic
por: Starkey, Samantha Y., et al.
Publicado: (2022) -
A case of antisynthetase syndrome with chilblains‐like lesions and microangiopathy
por: Abrassart, Tom, et al.
Publicado: (2021) -
Immunoglobulin A Antiphospholipid Antibodies in Patients With Chilblain-like Lesions During the COVID-19 Pandemic()
por: Cuenca Saez, M.A., et al.
Publicado: (2021) -
Negative SARS-CoV-2 PCR in patients with chilblain-like lesions
por: Hubiche, Thomas, et al.
Publicado: (2021)